From November 5th to 7th, we had the privilege of joining and chairing a session at the 16th Annual #PEGS Europe Summit.
Held at Montjuic Palau de Congressos in Fira #Barcelona, the event is celebrated as ‘the best hashtag#biologics technology meeting in Europe,’ attracting over 1,500 experts and innovators from across the globe.
Giuseppe Roscilli, our Chief Technology Officer, presented our latest advancements in #antibody engineering and innovative therapeutic strategies, with a focus on our groundbreaking work with bispecific antibodies targeting HER3.
It was an honor to lead discussions in the “Next-Generation Immunotherapies” session, which explored a range of innovative strategies including anti-TNFR2 strategies, IL-18 receptor antibody agonists, neoantigen vaccine optimization, and antibody-cytokine fusion proteins.
The conference featured extensive programs, such as Antibody and Protein Engineering, Oncology, Machine Learning & Data Science and Immunotherapy, highlighting the newest advancements and technologies of antibody-based treatments.
It was an incredible experience to network, exchange knowledge, and collaborate with leaders in the field.
Thanks to PEGS Europe for an inspiring and impactful event!
